검색어 : 통합검색[Orr Rebecca B.]
총 76건 중 76건 출력
, 1/8 페이지
-
1
- A Road Map for Planning Course Transformation Using Learning Objectives
- Orr, Rebecca B.; Gormally, Cara; Brickman, Peggy; Collin College, Collin Virtual Campus, McKinney, TX 75069; School of Science, Technology, Accessibility, Mathematics, and Public Health, Gallaudet University, Washington, DC 20002; University of Georgia, Department of Plant Biology, Athens, GA 30602; (CBE life sciences education, v.23, 2024, pp.es4)
-
2
- Abstract PO033: FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer
- Sengal, Asmerom; Smith, Deborah; Rogers, Rebecca; Snell, Cameron; Williams, Elizabeth; Pollock, Pamela; ; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.27, 2021, pp.PO033-PO033)
-
3
- Writing and Using Learning Objectives
- Orr, Rebecca B.; Csikari, Melissa M.; Freeman, Scott; Rodriguez, Michael C.; Division of Academic Affairs, Collin College, Plano, TX 75074; HHMI Science Education, BioInteractive, Chevy Chase, MD 20815; Department of Biology, University of Washington, Seattle, WA 98195; Educational Psychology, College of Education and Human Development, University of Minnesota, Minneapolis, MN 55455; (CBE life sciences education, v.21, 2022, pp.fe3)
-
4
- Epilepsy in children exposed to family and domestic violence in the first 5 years of life
- Orr, Carol; Fisher, Collen; O'Donnell, Melissa; Glauert, Rebecca; Preen, David B; The School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; The School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; The Australian Centre for Child Protection, The University of South Australia, Adelaide, South Australia, Australia; The School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; The School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; (Journal of paediatrics and child health, v.58, 2022, pp.2183-2189)
-
5
- Abstract CT155: Phase 2 study of sacituzumab govitecan (IMMU-132), an anti-Trop-2/SN-38 antibody-drug conjugate (ADC), in patients with pretreated metastatic small-cell lung cancer (mSCLC)
- Gray, Jhanelle E.; Heist, Rebecca S.; Starodub, Alexander N.; Camidge, D. Ross; Kio, Ebenezer; Masters, Gregory; Purcell, W. Thomas; Guarino, Michael J.; Misleh, Jamal; Schneider, Charles J.; Schneider, Bryan J.; Ocean, Allyson J.; Johnson, Tirrell; Gandhi, Leena; Kalinsky, Kevin; Govindan, Serengulam V.; Maliakal, Pius; Mudenda, Boyd; Wegener, William A.; Sharkey, Robert M.; Goldenberg, David M.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.77, 2017, pp.CT155-CT155)
-
6
- Maternal assault admissions are associated with increased risk of child protection involvement
- Orr, Carol; Preen, David B; Glauert, Rebecca; O'Donnell, Melissa; Fisher, Colleen; Sims, Scott; ; (International journal of population data science, v.3, 2018, )
-
7
- Abstract CT226: Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor
- Muzaffar, Jameel; Kirtane, Kedar; Redman, Rebecca; Yang, Muh-Hwa; Kim, Tae Min; Liu, Stephen; Lynch, Ryan; Brahmer, Julie; LoRusso, Patricia; Henick, Brian; Kim, Sung-bae; Feng, Yin-Hsun; Chisamore, Michael; Kassner, Paul; Brockstedt, Dirk; Nasrah, Nicole; Goyal, Rakesh; Ho, William Y.; Villaflor, Victoria; 1Duke University School of Medicine, Durham, NC; ; 2Moffitt Cancer Center, Tampa, FL; ; 3University of Louisville Brown Cancer Center, Louisville, KY; ; 4Taipei Veterans General Hospital, Taipei City, Taiwan; ; 5Seoul National University Hospital, Seoul, Republic of Korea; ; 6Georgetown University, Washington, DC; ; 7University of Washington, Seattle, WA; ; 8Johns Hopkins University School of Medicine, Baltimore, MD; ; 9Yale School of Medicine, New Haven, CT; ; 10Columbia University, New York, NY; ; 11Asan Medical Center, Seoul, Republic of Korea; ; 12Chi Mei Medical Center, Tainan, Taiwan; ; 13Merck & Co., Inc., Rahway, NJ; ; 14RAPT Therapeutics, Inc., South San Francisco, CA; ; 14RAPT Therapeutics, Inc., South San Francisco, CA; ; 14RAPT Therapeutics, Inc., South San Francisco, CA; ; 14RAPT Therapeutics, Inc., South San Francisco, CA; ; 14RAPT Therapeutics, Inc., South San Francisco, CA; ; 15City of Hope, Duarte, CA.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.CT226-CT226)
-
8
- Abstract 7526: Landscape of TIGIT and PD-L1 co-expression in solid tumors
- Pabla, Sarabjot; Senosain, Maria-Fernanda; Seager, R.J.; Parikh, Hardik; Van Roey, Erik; Gao, Shuang; Pulivendula, Yamuna; DePietro, Paul; Nesline, Mary; Dash, Durgapras; Conroy, Jeffrey M.; Hastings, Stephanie; Ko, Heidi; Strickland, Kyle C.; Previs, Rebecca A.; Severson, Eric; Eisenberg, Marcia; Caveney, Brian; Jensen, Taylor J.; Ramkissoon, Shakti; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp), Buffalo, NY; ; 2Labcorp Oncology, Burlington, NC; ; 2Labcorp Oncology, Burlington, NC; ; 2Labcorp Oncology, Burlington, NC; ; 2Labcorp Oncology, Burlington, NC; ; 2Labcorp Oncology, Burlington, NC; ; 3Labcorp, Burlington, NC.; 3Labcorp, Burlington, NC.; 2Labcorp Oncology, Burlington, NC; ; 2Labcorp Oncology, Burlington, NC; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.7526-7526)
-
9
- Abstract PD13-01: Balixafortide (a CXCR4 antagonist)+eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer: An international, randomized, phase 3 trial (FORTRESS)
- Kaufman, Peter; Martin, Miguel; Mayer, Ingrid; Vahdat, Linda; Pernas, Sonia; Schmid, Peter; McArthur, Heather; Dent, Rebecca; Rugo, Hope S; Barrios, Carlos; Bobirca, Alexandra; Ringeisen, Francois; Schmitter, Daniela; Cortes, Javier; University of Vermont Cancer Center, Burlington, VT; Hospital General Universitario Gregorio Marañ ó n, Madrid, Spain; Vanderbilt University Medical Center, Nashville, TN; Memorial Sloan Kettering Cancer Center, New York, NY; Institut Català d’Oncologia,L’Hospitalet, Barcelona, Spain; Queen Mary University of London, London, United Kingdom; Cedars-Sinai, Los Angeles, CA; National Cancer Center Singapore, Singapore, Singapore; University of California San Francisco, San Francisco, CA; Centro de Pesquisa em Oncologia, Hospital Sã o Lucas, PUCRS, Porto Alegre, Brazil; Polyphor Ltd, Allschwil, Switzerland; Polyphor Ltd, Allschwil, Switzerland; Polyphor Ltd, Allschwil, Switzerland; International Breast Cancer Center (IBCC), Institute of Oncology, Quironsalud Group, Madrid & Barcelona and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.82, 2022, pp.PD13-01-PD13-01)
-
10
- Exposure to family and domestic violence is associated with increased childhood hospitalisations
- Orr, Carol; Fisher, Colleen M.; Preen, David B.; Glauert, Rebecca A.; O’Donnell, Melissa; School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia; Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia; (PloS one, v.15, 2020, pp.e0237251)
QUICK MENU
